Real-world trial of graphene nanoplatelet-modified ready-mix concrete
Researchers are conducting a real-world trial of pristine graphene nanoplatelet modified ready materials to assess their performance on a large scale.
The integration of graphene nanoplatelets into ready-mix concrete (RMC) is under examination to determine its practical benefits and challenges. Previous research has shown that adding 0.01–0.1% graphene by binder weight can enhance the mechanical, durability, and electrical properties of concrete-like composites. This enhancement could also contribute to sustainability by reducing cement usage, thus decreasing the carbon footprint of concrete production. However, despite these potential benefits, the construction industry's adoption of graphene remains limited due to cost and inconsistent performance.
The inconsistent performance of graphene-enhanced concrete is influenced by variables such as the physical characteristics of the graphene platelets, dosage levels, exfoliation times, and application methods. These factors require further investigation in real-world, large-scale conditions. This study first developed an implementation method for non-oxidised pristine graphene modified concrete-like composites under controlled laboratory conditions. Subsequently, this method was tested in a real-world large-scale RMC trial.
The trial found that while pristine graphene nanoplatelets (P-GNP) did not improve the mechanical properties of the RMC, they had a significant impact on its durability. The study highlighted the challenges and limitations of scaling up P-GNP implementation in the concrete industry. It revealed that laboratory-scale protocols are not entirely suitable for large-scale applications. The findings provide insights into the real-world challenges of incorporating P-GNP into the RMC industry and suggest strategies to address these challenges in future research.
Source: Graphene Feed